Comparison · NCT03748420-sae
Adherence Intervention vs Usual Care: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Adherence Intervention vs Usual Care: serious adverse events. Trial comparisons, record NCT03748420-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03748420-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.194 | 0.18 | 0.209 | wilson | |
| Risk in group 2 | 0.198 | 0.184 | 0.214 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0042 | -0.0249 | 0.0164 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.979 | 0.881 | 1.09 | log | |
| Odds ratio, group 1 over group 2 | 0.974 | 0.854 | 1.11 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Adherence Intervention than on Usual Care | 238 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Adherence Intervention | Patients in the medication adherence enhanced clinical decision support received the enhanced decision support intervention over a 6 month period. Patients were accrued over 6 months and followed for 12 months at which point they were assessed for improved medication adherence and clinical outcomes. | 559 | 2,879 | EG001 |
| Group 2 | Usual Care | Patients in the usual care arm received the basic clinical decision support that is considered the standard of care at HealthPartners. Patients in this study group were accrued over 6 months and followed for 12 months at which point they were assessed for improved medication adherence and clinical outcomes. | 557 | 2,808 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- Safety monitoring started at a patients index date and continued for an average of 11.6 months after index date.
Source ClinicalTrials.gov
Trial
- Title
- Medication Adherence Clinical Decision Support
- NCT number
- NCT03748420
- Phases
- NA
- Conditions
- Hyperlipidemia, Hypertension, Diabetes, Medication Nonadherence
- Interventions
- Adherence Intervention
- Lead sponsor
- HealthPartners Institute
- Results first posted
- 2024-02-26
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03748420?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03748420-sae